Holding(s) in Company

AI SummaryClose X

Unicorn Asset Management Limited, through Unicorn AIM VCT plc, has acquired a significant stake in Fusion Antibodies plc, increasing its total voting rights to 6.66%, representing 8,320,366 shares, up from a previous holding of 5.65%. This notification, dated 02 February 2026, reflects an acquisition and a change in the breakdown of voting rights, with the total number of voting rights held in the issuer now standing at 8,320,366 out of a total of 125,021,878.

Disclaimer*

UK 100

Latest directors dealings